Justera Health Announces Director Resignation and Change to Fiscal Year End
Justera Health announced two significant corporate changes. First, the company reported the resignation of Richard Yoon from its Board of Directors, effective March 28, 2025. Yoon stepped down to pursue other professional opportunities.
The Board will continue under the leadership of Joshua Herman and Young Cho Lee, who remain committed to advancing the company's strategic initiatives and optimizing its asset portfolio value.
Additionally, Justera has modified its fiscal year end from December 31 to March 31. This change aims to better align the company's reporting cycle with its operational and strategic planning objectives.
Justera Health ha annunciato due importanti cambiamenti aziendali. In primo luogo, la società ha comunicato le dimissioni di Richard Yoon dal Consiglio di Amministrazione, con effetto dal 28 marzo 2025. Yoon si è dimesso per intraprendere altre opportunità professionali.
Il Consiglio continuerà sotto la guida di Joshua Herman e Young Cho Lee, che rimangono impegnati a portare avanti le iniziative strategiche dell'azienda e a ottimizzare il valore del portafoglio degli asset.
Inoltre, Justera ha modificato la chiusura dell'esercizio fiscale, spostandola dal 31 dicembre al 31 marzo. Questa modifica mira a migliorare l'allineamento del ciclo di rendicontazione con gli obiettivi operativi e di pianificazione strategica dell'azienda.
Justera Health anunció dos cambios corporativos importantes. Primero, la compañía informó la renuncia de Richard Yoon a su Junta Directiva, efectiva a partir del 28 de marzo de 2025. Yoon renunció para perseguir otras oportunidades profesionales.
La Junta continuará bajo el liderazgo de Joshua Herman y Young Cho Lee, quienes permanecen comprometidos con avanzar las iniciativas estratégicas de la empresa y optimizar el valor de su cartera de activos.
Además, Justera ha modificado el cierre de su año fiscal, cambiándolo del 31 de diciembre al 31 de marzo. Este cambio busca alinear mejor el ciclo de reportes de la empresa con sus objetivos operativos y de planificación estratégica.
Justera Health는 두 가지 중요한 기업 변화를 발표했습니다. 첫째, 회사는 Richard Yoon이 2025년 3월 28일부로 이사회에서 사임했다고 보고했습니다. 윤 이사는 다른 전문적 기회를 추구하기 위해 사임했습니다.
이사회는 Joshua Herman과 Young Cho Lee의 리더십 하에 계속 운영되며, 두 사람은 회사의 전략적 이니셔티브를 추진하고 자산 포트폴리오 가치를 최적화하는 데 전념하고 있습니다.
또한, Justera는 회계연도 종료일을 12월 31일에서 3월 31일로 변경했습니다. 이 변경은 회사의 보고 주기를 운영 및 전략 계획 목표와 더 잘 맞추기 위한 것입니다.
Justera Health a annoncé deux changements majeurs au sein de l'entreprise. Tout d'abord, la société a communiqué la démission de Richard Yoon de son Conseil d'administration, effective à compter du 28 mars 2025. Yoon a quitté son poste pour poursuivre d'autres opportunités professionnelles.
Le Conseil poursuivra ses activités sous la direction de Joshua Herman et Young Cho Lee, qui restent engagés à faire avancer les initiatives stratégiques de l'entreprise et à optimiser la valeur de son portefeuille d'actifs.
De plus, Justera a modifié la clôture de son exercice fiscal, la faisant passer du 31 décembre au 31 mars. Ce changement vise à mieux aligner le cycle de reporting de l'entreprise avec ses objectifs opérationnels et de planification stratégique.
Justera Health gab zwei bedeutende Unternehmensänderungen bekannt. Erstens meldete das Unternehmen den Rücktritt von Richard Yoon aus dem Vorstand, wirksam zum 28. März 2025. Yoon trat zurück, um andere berufliche Möglichkeiten zu verfolgen.
Der Vorstand wird weiterhin unter der Führung von Joshua Herman und Young Cho Lee agieren, die sich verpflichtet haben, die strategischen Initiativen des Unternehmens voranzutreiben und den Wert des Asset-Portfolios zu optimieren.
Zusätzlich hat Justera das Geschäftsjahresende vom 31. Dezember auf den 31. März geändert. Diese Änderung soll den Berichtszyklus des Unternehmens besser mit den operativen und strategischen Planungszielen in Einklang bringen.
- None.
- Director Richard Yoon resigned from Board
- Board size reduced after resignation
TORONTO, ON / ACCESS Newswire / April 30, 2025 / Justera Health Ltd. (CSE:VTAL)(OTC PINK:SCRSF) ("Justera" or the "Company") announces the resignation of Mr. Richard Yoon from its Board of Directors, effective March 28, 2025, as well as a change to its fiscal year end.
Mr. Yoon has stepped down from the Board to pursue other professional opportunities. The Company thanks him for his contributions and service, and wishes him continued success in his future endeavors. The Board will continue to be led by Mr. Joshua Herman and Mr. Young Cho Lee, who remain focused on advancing the Company's strategic initiatives and maximizing the value of its asset portfolio.
In addition, Justera has changed its fiscal year end from December 31 to March 31, aligning its reporting cycle more closely with operational and strategic planning objectives.
About Justera Health
Established in 2020, Justera is a Canadian company focused on health and wellness. Through its services, innovative products, strategic partnerships, Justera empowers individuals to prioritize their well-being. With four subsidiaries, it offers personalized healthcare services and solutions, such as IV Vitamin Therapy, premium nutritional supplements through its Naturevan Nutrition brand, a full 360-degree wellness and spa experience through Juillet Wellness that provides registered massage therapy, acupuncture, and new retail stores in Vancouver. Justera's mission is to enhance Canadians overall well-being with diverse solutions catering to individual needs.
For additional information on Justera Health and other corporate information, please visit the Company's website at https://www.justerahealth.com/
For more information about the Company, please refer to the Company's profile on SEDAR+ at www.sedarplus.com.
For further information:
Investor Relations & Communications
Paul Haber, CFO
Tel: (416) 318-6501
Email: info@justerahealth.com
Forward-Looking Statements:
Certain statements contained in this news release may constitute forward-looking information, including statements relating to the future development of Justera's business. Forward-looking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions. All statements included herein, other than statements of historical fact, are forward-looking statements, including but not limited to: the terms, timing and completion of the Transaction, if the Transaction is to close at all, the receipt of all necessary regulatory and CSE approvals, authorizations and consents in connection with the Transaction, and the completion or waiver, as applicable, of all conditions precedent required for the completion of the Transaction; the anticipated business plans, management structure, and future activities of the Company and Port North, including the Company's intention to integrate Port North into its business; and the anticipated benefits and synergies to be derived from the Transaction on the business of both Port North and the Company; and the date in which the Payment Shares may become free-trading.
Forward-Looking Statements are based on assumptions, estimates, analyses and opinions of management of the Company at the time they were provided or made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, including: (i) successful completion of the Financing; (ii) successful completion of the Transaction and the integration of the business of Port North in connection therewith; (iii) the ability to manage anticipated and unanticipated costs; (iv) achieving the anticipated results of the Company's strategic plans; (v) obtaining and maintaining all required licenses, approvals and permits, including regulatory approvals required to complete the Transaction; and (vi) general economic, financial market, regulatory and political conditions in which the Company operates.
Forward-looking information involves known and unknown risks, uncertainties, and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. The actual results of Justera could differ materially from those anticipated in this forward-looking information as a result of the inability of Port North to complete the Financing, the inability to consummate the Transaction, including the inability to obtain required regulatory approvals and third-party consents and the satisfaction of other conditions, inputs, suppliers and skilled labour being unavailable or available only at uneconomic costs; changes in general economic, business and political conditions, including changes in the financial markets, changes in applicable laws generally and adverse future legislative and regulatory developments involving medical and recreational marijuana, competitive factors in the industries in which Justera operates, prevailing economic conditions, changes to Justera's strategic growth plans, and other factors, many of which are beyond the control of Justera.
Management of Justera believes that the expectations reflected in the forward-looking information herein are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking information should not be unduly relied upon. Any forward‐looking information contained in this news release represents Justera's expectations as of the date hereof and is subject to change after such date. Justera disclaims any intention or obligation to update or revise any forward‐looking information whether as a result of new information, future events, or otherwise, except as required by applicable securities legislation.
Neither the Canadian Securities Exchange (the "CSE") nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
###
SOURCE: Justera Health Ltd.
View the original press release on ACCESS Newswire
FAQ
When did Richard Yoon resign from Justera Health (SCRSF) board of directors?
What is the new fiscal year end date for Justera Health (SCRSF)?
Who remains on Justera Health (SCRSF) board after Richard Yoon's resignation?
Why did Justera Health (SCRSF) change its fiscal year end date?
What changes did Justera Health (SCRSF) announce on April 30, 2025?
